In terms of the hospital partners of Theranos, the Cleveland Clinic has gotten much of the attention. However, there is another announced hospital relationship of note with Intermountain Healthcare (see: Doctor Questions Theranos as His Employer Plans Lab-Test Pilot; This CEO is out for blood). Below is an excerpt from the first link published on October 16, 2015:
A senior doctor at one of Theranos Inc.’s partners for a pilot program of its blood-testing technology questioned the accuracy of the startup’s tests, adding to mounting criticism of the Silicon Valley company.....The Wall Street Journal reported...that the health-care startup, which the newspaper valued at $9 billion, has used the same technology as its competitors for most of its blood tests, undermining the company’s promotion of its technology as an advance in the healthcare industry. "Theranos has refused to disclose their methods, they have never made their data public, they have not gone through the peer review process," Joel Ehrenkranz, director of endocrinology at Utah-based hospital system Intermountain Healthcare, said during an interview with Emily Chang on Bloomberg Television...."They don’t play by the rules of science or medicine. They are not transparent."A spokesman for Intermountain said Ehrenkranz wasn’t speaking for the hospital system. In an interview ....Theranos Chief Executive Officer Elizabeth Holmes responded to Ehrenkranz’s comments, saying the medical industry is typically resistant to change."It is completely normal for someone to say, ‘I don’t know if this is real,’" she said.....Theranos and Intermountain are still planning their limited pilot program for blood testing, and a start date hasn’t been determined....Intermountain will run the study at one clinic where Theranos technology will be used alongside traditional blood testing.... Ehrenkranz isn’t involved in the pilot program...."Within the industry, the consensus is that this is too good to be true," he said.
It's unusual for a lone-wolf critic of a major enterprise like Intermountain Healthcare to get attention. We thus need to give credit to Emily Chang on Bloomberg Television for bringing Dr. Ehrenkranz's opinion to the forefront. However and more importantly, I want to emphasize his integrity and courage for speaking out in the face of an announced relationship of his large health system employer. Note the sentence above: A spokesman for Intermountain said Ehrenkranz wasn’t speaking for the hospital system. I suspect that this spokesperson might want to rephrase this announcement in the light of recent events.
The specific nature of the relationship between Intermountain and Theranos has never been detailed other than it's pilot program. However, Intermountain also has an excellent reference lab that could be used by Theranos for referral of some its esoteric testing. To finish, let me just reiterate the prescient quote from Dr. Ehrenkranz that a lot of other lab professionals were thinking but not saying to the press: Within the industry, the consensus is that...[the Theranos story] is too good to be true.